David Hung
Fondateur chez NUVATION BIO INC.
Fortune : 173 M $ au 30/06/2024
Profil
David T.
Hung was the founder of Medivation, Inc. (founded in 2003) and Medivation LLC (California) (founded in 1995), where he served as President, Chief Executive Officer & Director until 2016.
He is also the founder of Nuvation Bio Operating Co., Inc. (founded in 2018) and Nuvation Bio, Inc. (founded in 2018), where he currently holds the position of President, Chief Executive Officer & Director.
Dr. Hung is also the founder of Repharmation, Inc. Dr. Hung's current jobs include being an Independent Director at NovoCure Ltd.
since 2018, a Director at Establishment Labs SA since 2016, and a Director at Auransa, Inc. Dr. Hung's former jobs include being the President & Chief Executive Officer of Orion Acquisition Corp.
II, President, Chief Executive Officer & Director of Pro-Duct Health, Inc. from 1999 to 2001, President, Chief Executive Officer & Director of Medivation Neurology LLC from 2011 to 2016, Chief Executive Officer & Director of Sio Gene Therapies, Inc. from 2017 to 2018, and Chief Executive Officer & Director of Axovant Sciences, Inc. from 2017 to 2018.
He has also held positions as a Director at Agilvax, Inc., Solbec Pharmaceuticals Ltd., Opexa Therapeutics, Inc., NKT Therapeutics, Inc., and Roivant Sciences GmbH.
Additionally, Dr. Hung served as an Independent Director at Establishment Labs Holdings, Inc. from 2016 to 2021 and as an Independent Director at ARYA Sciences Acquisition Corp.
from 2018 to 2021.
He was also the VP-Lead Discovery, Development & New Projects at Chiron Corp.
from 1996 to 1998 and a Consultant at Cytyc Health Corp.
in 2003.
Dr. Hung's education includes an undergraduate degree from Harvard College and a doctorate from UCSF School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUVATION BIO, INC. CLASS A
23,58% | 15/04/2024 | 58 281 054 ( 23,58% ) | 170 M $ | 30/06/2024 |
NUVATION BIO, INC.
6,37% | 15/04/2024 | 1 000 000 ( 6,37% ) | 3 M $ | 30/06/2024 |
NOVOCURE LTD.
0,01% | 05/06/2024 | 13 194 ( 0,01% ) | 226 013 $ | 30/06/2024 |
Postes actifs de David Hung
| Sociétés | Poste | Début |
|---|---|---|
| NOVOCURE LIMITED | Directeur/Membre du Conseil | 31/05/2018 |
| NUVATION BIO INC. | Fondateur | 20/03/2018 |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Fondateur | 01/01/2018 |
Auransa, Inc.
 Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | Directeur/Membre du Conseil | - |
| Repharmation, Inc. | Fondateur | - |
Establishment Labs SA
 Establishment Labs SA Medical SpecialtiesHealth Technology Establishment Labs SA is a medical device and aesthetics firm. It designs, develops, manufactures, and ,markets advanced silicon-filled breast and body shaping implants. The company was founded by Juan José Chacon Quiros in 2004 and is headquartered in Alajuela, Costa Rica. | Directeur/Membre du Conseil | 01/02/2016 |
Anciens postes connus de David Hung
| Sociétés | Poste | Fin |
|---|---|---|
| ESTABLISHMENT LABS HOLDINGS INC. | Directeur/Membre du Conseil | 11/02/2021 |
| ARYA SCIENCES ACQUISITION III A | Directeur/Membre du Conseil | 01/01/2021 |
| SIO GENE THERAPIES INC. | Directeur Général | 12/02/2018 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de David Hung
| Harvard College | Undergraduate Degree |
| UCSF School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NOVOCURE LIMITED | Health Technology |
| ESTABLISHMENT LABS HOLDINGS INC. | Health Technology |
| NUVATION BIO INC. | Health Technology |
| Entreprise privées | 19 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
| Orion Acquisition Corp. II | Finance |
Agilvax, Inc.
 Agilvax, Inc. BiotechnologyHealth Technology Agilvax, Inc. discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. It optimizes lead immunotherapy candidates through an extensive in vitro and in vivo testing process to ensure clinical efficacy. The company was founded in 2011 and is headquartered in Albuquerque, NM. | Health Technology |
| Solbec Pharmaceuticals Ltd. | Health Technology |
Pro-Duct Health, Inc.
 Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Pro·Duct Health manufactures the devices used in ductal lavage. The company is dedicated to eradicating breast cancer by enabling the earliest possible detection of breast pre-cancer and cancer | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Medivation Neurology LLC
 Medivation Neurology LLC BiotechnologyHealth Technology Part of Pfizer Inc., Medivation Neurology LLC develops and produces biopharmaceutical products. The company is based in San Francisco, CA. | Health Technology |
| Cytyc Health Corp. | |
NKT Therapeutics, Inc.
 NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA. | Health Technology |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Establishment Labs SA
Establishment Labs SA Medical SpecialtiesHealth Technology Establishment Labs SA is a medical device and aesthetics firm. It designs, develops, manufactures, and ,markets advanced silicon-filled breast and body shaping implants. The company was founded by Juan José Chacon Quiros in 2004 and is headquartered in Alajuela, Costa Rica. | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
Auransa, Inc.
Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | Health Technology |
ARYA Sciences Acquisition Corp.
 ARYA Sciences Acquisition Corp. Financial ConglomeratesFinance ARYA Sciences Acquisition Corp. is an organized blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination with one or more entities. The company was founded by Joseph Eric Edelman, Adam Stone and Michael Altman in June 2018 and is headquartered in New York, NY. | Finance |
| Repharmation, Inc. | |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Health Technology |
